Cargando…
Safe and Effective Use of Chronic Transdermal Estradiol for Life-Threatening Uremic Bleeding in a Patient with Coronary Artery Disease
Uremic platelet dysfunction rarely causes significant bleeding in adequately dialyzed patients. When encountered, the management is complicated by a lack of well-supported treatment modalities. Estrogen use in uremic platelet dysfunction has been described, but enthusiasm for the treatment has been...
Autores principales: | Bali, Atul, Hix, John Kevin, Kouides, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164069/ https://www.ncbi.nlm.nih.gov/pubmed/25337082 http://dx.doi.org/10.1159/000365480 |
Ejemplares similares
-
Transdermal estradiol in castrate and chemotherapy resistant prostate cancer
por: Stein, Mark, et al.
Publicado: (2012) -
Life-threatening subclavian artery bleeding following percutaneous coronary intervention with stent implantation: A case report and review of literature
por: Shi, Fei, et al.
Publicado: (2022) -
CoolClot, a novel hemostatic agent for controlling life-threatening arterial bleeding
por: Mortazavi, SMJ, et al.
Publicado: (2013) -
Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing
por: Trovato, Alexa, et al.
Publicado: (2021) -
Enhanced Skin Permeation of Estradiol by Dimethyl Sulfoxide Containing Transdermal Patches
por: Otterbach, Anna, et al.
Publicado: (2021)